Eli Lilly (LLY), the maker of the blockbuster weight-loss drug Zepbound, announced Wednesday that it plans to invest $27 ...
ELI LILLY and Company is collaborating with experts on innovative research on the effects of translocation and climate change on indigenous grassland species. The new Lilly Limerick biopharmaceutical ...
Eli Lilly is playing its part in helping conserve local wildlife with the relocation of a rare meadow barley species on its ...
Eli Lilly has said it is seeking permission to ... The pharma group has said the total investment in the proposed facility in Limerick would be more than €400 million ($445 million), and could ...
Micheál Martin may need to pledge some material incentives to increase the size of Irish business investors in the US ...
Eli Lilly has unveiled a $27 billion (€25.7 billion) investment in US manufacturing facilities as the pharmaceutical industry prepares for the threat of tariffs and mounts a charm offensive ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results